Vivint Smart Home Names Dana Russell CFO, Succeeding Dale Gerard - Quick Facts

Smart-home solutions company Vivint Smart Home, Inc. (VVNT) announced Monday the appointment of Dana Russell as its chief financial officer.

Russell succeeds Dale Gerard, who will be stepping down as CFO effective May 31 to accept a new role with a company outside of the smart home industry.

Russell will begin his tenure as CFO immediately to help facilitate a smooth transition. He was Vivint Solar's chief financial officer from 2013 to 2020. Russell became the CFO of Vivint Solar in December of 2013 and helped take the company public in October of 2014. He was in the post until the company's acquisition by Sunrun in October of 2020 in a transaction valued at $5.4 billion at the time of closing.

He has more than 25 years of finance and operational expertise, most of which has been spent with technology and service businesses.

Gerard, during his 12 years at Vivint Smart Home, has served in various senior finance roles and helped taking the company public in January 2020.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Longmont Colorado -based Royal Crest Dairy is recalling 2% Chocolate Milk citing the potential to be contaminated with undeclared egg, a known allergen, the U.S. Food and Drug Administration said. The recall involves Farmer's 2% Reduced Fat Chocolate Milk Pints with the code date of AUG-22. ANI Pharmaceuticals, Inc. (ANIP) Monday announced a wider loss for the second quarter, despite a 52 percent surge in revenues. For the full year 2022, the company reiterated the adjusted earnings per share range, revenue guidance and raised Cortrophin revenue outlook. The company reported a quarterly... Shares of BioNTech SE were losing around 4 percent in the morning trading in Germany and around 5 percent in the pre-market activity on Nasdaq after the German Covid-19 vaccine maker reported sharp drop in profit and revenues for the second quarter. However, the company recorded strong growth in first-half results. Further, the company maintained BioNTech COVID-19 vaccine revenue guidance
Follow RTT